Well Referenced

Tag: genitourinary syndrome

The 2022 hormone therapy position statement of The North American Menopause Society

This 2022 position statement by the North American Menopause Society (NAMS) updates the 2017 guidance on hormone therapy (HT) for menopausal individuals. HT remains the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause and is shown to prevent bone loss and fractures. The benefits and risks of

June 26, 2025 No Comments

Management of Menopausal Symptoms: A Review

This review discusses the management of menopausal symptoms, focusing on the effectiveness of hormonal and non-hormonal treatments. It highlights that systemic estrogen therapy is the most effective treatment for managing vasomotor symptoms, providing a 75% reduction in symptoms. However, it also addresses the associated risks, including increased chances of stroke,

June 26, 2025 No Comments